1. Immunology/Inflammation Anti-infection
  2. CD1 IFNAR Interleukin Related Bacterial Influenza Virus
  3. Glycolipid C34

Glycolipid C34,一种 α-GalCer (HY-102022) 类似物,是一种 CD1d 结合型糖脂类抗感染剂。Glycolipid C34 介导恒定自然杀伤 T 细胞活化,并促进 IFN-γIL-4 的分泌。Glycolipid C34 可在小鼠模型中促进细菌感染的清除,并增强针对病毒感染的保护性免疫。Glycolipid C34 可用于细菌感染、病毒感染的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Glycolipid C34

Glycolipid C34 Chemical Structure

CAS No. : 1204401-08-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Glycolipid C34, α-GalCer (HY-102022) analog, is a CD1d-binding glycolipid antinfection agent. Glycolipid C34 mediates invariant natural killer T cell activation and increases the secretion of IFN-γ and IL-4. Glycolipid C34 promotes clearance of bacterial infections in murine models and enhances protective immunity against viral infections. Glycolipid C34 can be used for the research of bacterial infection, viral infection[1].

IC50 & Target[1]

CD1d

 

IL-4

 

体外研究
(In Vitro)

Glycolipid C34 可通过结合 CD1d 介导恒定自然杀伤 T 细胞活化,并促进 IFN-γIL-4 的分泌[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Glycolipid C34 (50 μg/kg;腹腔注射;单剂量;感染后 3 小时) 可显著降低 Sphingomonas capsulata 感染的 C57BL/6 小鼠肝脏细菌载量[1]
Glycolipid C34 (150 μg/kg;腹腔注射;单次给药;感染后 3 小时) 可显著降低 S. aureus Xen29 大腿感染 BALB/c 小鼠的细菌载量[1]
Glycolipid C34 (150 μg/kg;腹腔注射;单剂量;感染后 0-6 h) 立即给药可显著降低 S. aureus Xen29 大腿感染的 BALB/c 小鼠的细菌载量,而延迟给药 (感染后 6 小时) 的疗效会下降[1]
Glycolipid C34 (1 μg;腹腔注射;2 次给药;攻毒前 1 天和攻毒后 1 天) 可提升感染 JEV 和 WSN 的 C57BL/6 小鼠的存活率,且其保护作用依赖于完整的固有免疫和适应性免疫组分[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (female, 6 to 8 weeks old; Sphingomonas capsulata infection model)[1]
Dosage: 50 μg/kg
Administration: i.p.; single dose; 3 hours post-infection
Result: Significantly reduced liver bacterial CFU counts compared to vehicle control (P < 0.01), with mean CFU counts lower than those seen with α-GalCer treatment.
Animal Model: BALB/c (female; Staphylococcus aureus Xen29 deep thigh wound infection model)[1]
Dosage: 150 μg/kg
Administration: i.p.; single dose; 0, 3, 6 hours post-infection
Result: Significantly reduced relative luminescence units (a marker of bacterial burden) compared to vehicle control (P < 0.05), with a greater degree of bacterial clearance than seen with α-GalCer treatment.
Animal Model: C57BL/6 (7 weeks old; Japanese encephalitis virus RP-9 strain and influenza virus WSN infection model)[1]
Dosage: 1 μg
Administration: i.p.; two doses; 1 day pre-challenge and 1 day post-challenge
Result: Significantly prolonged survival compared to vehicle control.
分子量

834.11

Formula

C47H76FNO10

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Glycolipid C34
目录号:
HY-186103
需求量: